Macclesfield, United Kingdom

Bernd Harald Liepold

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Bernd Harald Liepold: Innovator in Pharmaceutical Formulations

Introduction

Bernd Harald Liepold is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 4 patents to his name, Liepold's work focuses on enhancing the bioavailability of pharmaceutical compounds.

Latest Patents

One of his latest patents involves an immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one. This invention relates to a pharmaceutical formulation that includes the drug in a solid dispersion with a matrix polymer exhibiting low hygroscopicity and high softening temperature, such as copovidone. The formulation aims to provide a daily pharmaceutical dose of the drug while increasing its bioavailability through the use of the specified matrix polymer.

Career Highlights

Liepold's career is marked by his dedication to pharmaceutical innovation. His work has been instrumental in developing formulations that improve drug delivery and efficacy. He is currently associated with Kudos Pharmaceuticals Limited, where he continues to advance his research and development efforts.

Collaborations

Throughout his career, Liepold has collaborated with several professionals in the field, including Michael Karl Bechtold and Julie Kay Cahill. These collaborations have contributed to the success of his projects and the advancement of pharmaceutical science.

Conclusion

Bernd Harald Liepold is a distinguished inventor whose work in pharmaceutical formulations has made a significant impact on drug delivery systems. His innovative approaches continue to enhance the effectiveness of medications, benefiting the healthcare industry and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…